<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Spark Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitability of genetic disease by working to discover, develop and deliver gene therapies that address inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $352,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Jeffrey D. Marrazzo
    • FOUNDED
      2013
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Betterpath, Inc.

    Betterpath, Inc.

    Betterpath makes the benefit of health data ownership clear, reconciling crucial s...

    Betterpath makes the benefit of health data own...

    Amount Raised:    $8,800,000
    Fundraising Status:    EC
    Filing Type:    CF
    Evogene Ltd.

    Evogene Ltd.

    Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel p...

    Evogene (NASDAQ, TASE: EVGN) is a leading biote...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    Entera Bio Ltd.

    Entera Bio Ltd.

    Entera Bio is a clinical-stage biopharmaceutical company focused on the developmen...

    Entera Bio is a clinical-stage biopharmaceutica...

    Filing Type:    PU
    Menlo Therapeutics Inc.

    Menlo Therapeutics Inc.

    We are a late stage biopharmaceutical company focused on the development and comme...

    We are a late stage biopharmaceutical company f...

    Filing Type:    PU
    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicat...

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI...

    Filing Type:    PU
    Orchard Therapeutics plc

    Orchard Therapeutics plc

    Orchard Therapeutics is a fully integrated commercial-stage biopharmaceutical comp...

    Orchard Therapeutics is a fully integrated comm...

    Filing Type:    PU
    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into ...

    Sangamo Therapeutics, Inc. is focused on transl...

    Filing Type:    PU
    Tocagen Inc.

    Tocagen Inc.

    Tocagen is a clinical-stage, cancer-selective gene therapy company developing firs...

    Tocagen is a clinical-stage, cancer-selective g...

    Filing Type:    PU
    Synlogic, Inc.

    Synlogic, Inc.

    Synlogic™ is pioneering the development of a novel class of living Synthetic Bio...

    Synlogic™ is pioneering the development of a ...

    Filing Type:    PU
    Stoke Therapeutics, Inc.

    Stoke Therapeutics, Inc.

    Stoke is pioneering a new way to treat the underlying cause of severe genetic dise...

    Stoke is pioneering a new way to treat the unde...

    Filing Type:    PU
    BridgeBio Pharma, Inc.

    BridgeBio Pharma, Inc.

    BridgeBio finds, develops, and delivers breakthrough medicines for genetic disease...

    BridgeBio finds, develops, and delivers breakth...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.